Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guofeng Chen

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
BMC Gastroenterology|May 4, 2019
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in ChinaJian Sun, Huiguo Ding, Guofeng Chen, et al.
Hepatology (Baltimore, Md.)|December 17, 2021
Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter studyChun-Yan Wang, Ya Deng, Ping Li, et al.
Cell Metabolism|June 19, 2024
Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancerYu Jiang, Yawen Wang, Guofeng Chen, et al.
Cancer Research|October 28, 2025
Artificial Intelligence and Multimodality Data Integration Decipher Tertiary Lymphoid Structure Maturity in Gastric CancerWenxuan Wu, Zhenzhen Xun, Yaxuan Han, et al.
Medicine|November 29, 2016
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitisHong Ma, Minde Zeng, Ying Han, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatmentYameng Sun, Jialing Zhou, Lin Wang, et al.
Omics : a Journal of Integrative Biology|June 12, 2020
A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B VirusMin Cong, Xiaojuan Ou, Jian Huang, et al.
The Lancet. Gastroenterology & Hepatology|December 6, 2016
Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept studyGeorge Lau, Yves Benhamou, Guofeng Chen, et al.
Journal of Medical Virology|March 25, 2019
On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon α add-on therapyTianhui Liu, Yameng Sun, Jialing Zhou, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 10, 2014
Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: a randomized trialJun Cheng, Yuming Wang, Jinlin Hou, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
BMC Gastroenterology|May 4, 2019
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in ChinaJian Sun, Huiguo Ding, Guofeng Chen, et al.
Hepatology (Baltimore, Md.)|December 17, 2021
Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter studyChun-Yan Wang, Ya Deng, Ping Li, et al.
Cell Metabolism|June 19, 2024
Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancerYu Jiang, Yawen Wang, Guofeng Chen, et al.
Cancer Research|October 28, 2025
Artificial Intelligence and Multimodality Data Integration Decipher Tertiary Lymphoid Structure Maturity in Gastric CancerWenxuan Wu, Zhenzhen Xun, Yaxuan Han, et al.
Medicine|November 29, 2016
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitisHong Ma, Minde Zeng, Ying Han, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatmentYameng Sun, Jialing Zhou, Lin Wang, et al.
Omics : a Journal of Integrative Biology|June 12, 2020
A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B VirusMin Cong, Xiaojuan Ou, Jian Huang, et al.
The Lancet. Gastroenterology & Hepatology|December 6, 2016
Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept studyGeorge Lau, Yves Benhamou, Guofeng Chen, et al.
Journal of Medical Virology|March 25, 2019
On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon α add-on therapyTianhui Liu, Yameng Sun, Jialing Zhou, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 10, 2014
Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: a randomized trialJun Cheng, Yuming Wang, Jinlin Hou, et al.
Pageof 12